PACIRA BIOSCIENCES, INC. Available-for-sale Securities, Gross Unrealized Losses (Deprecated 2013-01-31)
PACIRA BIOSCIENCES, INC. (PCRX) had Available-for-sale Securities, Gross Unrealized Losses (Deprecated 2013-01-31) of $14.00 thousand as of 2013-09-30, per its 10-Q filed 2013-10-31.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecuritiesGrossUnrealizedLosses1 · last filed 2013-10-31
- 2013-09-30: Available-for-sale Securities, Gross Unrealized Losses (Deprecated 2013-01-31) $14.00K.
- 2013-06-30: Available-for-sale Securities, Gross Unrealized Losses (Deprecated 2013-01-31) $37.00K.
- 2013-03-31: Available-for-sale Securities, Gross Unrealized Losses (Deprecated 2013-01-31) $22.00K.
- 2012-12-31: Available-for-sale Securities, Gross Unrealized Losses (Deprecated 2013-01-31) $1.00K.
| Period end | Available-for-sale Securities, Gross Unrealized Losses (Deprecated 2013-01-31) |
|---|---|
| 2013-09-30 | $14.00K 10-Q · filed 2013-10-31 |
| 2013-06-30 | $37.00K 10-Q · filed 2013-08-06 |
| 2013-03-31 | $22.00K 10-Q · filed 2013-05-08 |
| 2012-12-31 | $1.00K 10-Q · filed 2013-10-31 |
| 2012-09-30 | $2.00K 10-Q · filed 2012-11-01 |
| 2012-06-30 | $4.00K 10-Q · filed 2012-08-09 |
| 2011-12-31 | $10.00K 10-K · filed 2013-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |